204 related articles for article (PubMed ID: 18594325)
21. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study.
King J; Mochalski P; Kupferthaler A; Unterkofler K; Koc H; Filipiak W; Teschl S; Hinterhuber H; Amann A
Physiol Meas; 2010 Sep; 31(9):1169-84. PubMed ID: 20664160
[TBL] [Abstract][Full Text] [Related]
22. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic potential of breath analysis--focus on volatile organic compounds.
Miekisch W; Schubert JK; Noeldge-Schomburg GF
Clin Chim Acta; 2004 Sep; 347(1-2):25-39. PubMed ID: 15313139
[TBL] [Abstract][Full Text] [Related]
24. Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath.
Beauchamp J
J Breath Res; 2011 Sep; 5(3):037103. PubMed ID: 21654021
[TBL] [Abstract][Full Text] [Related]
25. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
[TBL] [Abstract][Full Text] [Related]
26. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
[TBL] [Abstract][Full Text] [Related]
27. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology.
Caldeira M; Barros AS; Bilelo MJ; Parada A; Câmara JS; Rocha SM
J Chromatogr A; 2011 Jun; 1218(24):3771-80. PubMed ID: 21546028
[TBL] [Abstract][Full Text] [Related]
28. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds.
Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316
[TBL] [Abstract][Full Text] [Related]
29. Halitosis associated volatiles in breath of healthy subjects.
van den Velde S; Quirynen M; van Hee P; van Steenberghe D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):54-61. PubMed ID: 17416556
[TBL] [Abstract][Full Text] [Related]
30. Temperature-programmed gas chromatography linear retention indices of all C4-C30 monomethylalkanes on methylsilicone OV-1 stationary phase. Contribution towards a better understanding of volatile organic compounds in exhaled breath.
Krkosová Z; Kubinec R; Soják L; Amann A
J Chromatogr A; 2008 Jan; 1179(1):59-68. PubMed ID: 18021789
[TBL] [Abstract][Full Text] [Related]
31. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury.
Bos LD; van Walree IC; Kolk AH; Janssen HG; Sterk PJ; Schultz MJ
J Appl Physiol (1985); 2013 Nov; 115(10):1487-95. PubMed ID: 23908314
[TBL] [Abstract][Full Text] [Related]
32. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
[TBL] [Abstract][Full Text] [Related]
33. Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers.
Ruzsanyi V; Baumbach JI; Sielemann S; Litterst P; Westhoff M; Freitag L
J Chromatogr A; 2005 Aug; 1084(1-2):145-51. PubMed ID: 16114247
[TBL] [Abstract][Full Text] [Related]
34. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry.
Deng C; Zhang X; Li N
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):269-77. PubMed ID: 15261821
[TBL] [Abstract][Full Text] [Related]
35. The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?
Keogh RJ; Riches JC
Curr Oncol; 2022 Sep; 29(10):7355-7378. PubMed ID: 36290855
[TBL] [Abstract][Full Text] [Related]
36. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.
Kubáň P; Foret F
Anal Chim Acta; 2013 Dec; 805():1-18. PubMed ID: 24296139
[TBL] [Abstract][Full Text] [Related]
37. New graphene fiber coating for volatile organic compounds analysis.
Zhang G; Guo X; Wang S; Wang X; Zhou Y; Xu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():128-31. PubMed ID: 25171504
[TBL] [Abstract][Full Text] [Related]
38. Breath analysis during one-lung ventilation in cancer patients.
Kischkel S; Miekisch W; Fuchs P; Schubert JK
Eur Respir J; 2012 Sep; 40(3):706-13. PubMed ID: 22267752
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer biomarkers in exhaled breath.
Amann A; Corradi M; Mazzone P; Mutti A
Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
[TBL] [Abstract][Full Text] [Related]
40. Differences between alveolar air and mouth air.
van den Velde S; Quirynen M; van Hee P; van Steenberghe D
Anal Chem; 2007 May; 79(9):3425-9. PubMed ID: 17378538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
